Infectious Diseases 1702 - Infectious Disease Alert - Feb 01, 2013

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Hospital Epidemiologist
Sequoia Hospital
Redwood City, CA

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Dean L. Winslow, MD, FACP, FIDSA
Chairman, Department of Medicine
Santa Clara Valley, Medical Center
Clinical Professor
Stanford University School of Medicine

Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
Associate Professor of Internal Medicine,
Northeast Ohio Medical University
Rootstown, OH

Hal B. Jenson, MD, FAAP
Dean
Western Michigan University School of Medicine
Kalamazoo, MI

Subjects:

  • Surgeon-To-Patient HBV Transmission, CDC Update on Chronically Infected
  • Meningoencephalitis due to Borrelia miyamotoi
  • Delayed Primary Epstein-Barr Virus Infection: Clinical and Immunologic Manifestations
  • Pediatric Tuberculosis in the United States
  • Tetracycline Treatment of Mycoplasma Infections in Children
  • FluBlok - The First FDA-Approved Recombinant Seasonal Influenza Vaccine
  • Rapid Identification of Gastro Pathogens Directly from Stool
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, Associate Editor Richard R. Watkins, MD, MS, FACP, and Hal B. Jenson, MD, FAAP) report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA is a consultant for Siemens Diagnostic..

Copyright 2013 AHC Media. All rights reserved.